Top Markets
Coin of the day
Renascience Inc. Renascience Inc.

Renascience Inc.

4889
Kedudukan dalam Saham #21014
Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively... Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets. Another PAI-1 inhibitor, RS5441, is currently in Phase 1 trials for various dermatological conditions. Additionally, RS8001, a water-soluble vitamin, is undergoing Phase 2 clinical development for the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. Beyond its pharmaceutical ventures, Renascience is also advancing the RS9001 disposable ultrafine endoscope, alongside developing artificial intelligence-driven medical solutions and comprehensive diagnostic tools.
Harga Saham
$8.49
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$117.03M
Perubahan (1 hari)
-4.82%
Perubahan (1 tahun)
-45.48%
Negara
JP
Perdagangan Renascience Inc. (4889)

Kategori

Sejarah harga saham bagi Renascience Inc. (4889)
Harga penutupan tertinggi: $8.43 pada 2026-08-01

Harga penutupan terendah: $7.05 pada 2021-09-01
Sejarah harga saham Renascience Inc. dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 2.00%
2025 471.92%
2024 -36.21%
2023 18.40%
2022 -62.92%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH